From Wikipedia, the free encyclopedia
Both CA 15-3 and CA 27-29 may be elevated in patients with benign ovarian cysts, benign breast disease, and benign liver disease. Elevations may also be seen in cirrhosis, sarcoidosis and lupus.
- http://www.oncolink.org/experts/article.cfm?c=3&s=13&ss=22&id=1911 "CA15-3"
- Duffy MJ, Duggan C, Keane R, et al. (March 2004). "High preoperative CA 15-3 concentrations predict adverse outcome in node-negative and node-positive breast cancer: study of 600 patients with histologically confirmed breast cancer". Clin. Chem. 50 (3): 559–63. PMID 14726467. doi:10.1373/clinchem.2003.025288.
- CA-15-3 Antigen at the US National Library of Medicine Medical Subject Headings (MeSH)
- Bearz A, Talamini R, Vaccher E, et al. (2007). "MUC-1 (CA 15-3 antigen) as a highly reliable predictor of response to EGFR inhibitors in patients with bronchioloalveolar carcinoma: an experience on 26 patients". Int. J. Biol. Markers. 22 (4): 307–11. PMID 18161663.
- CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials - Keshaviah et al. 18 (4): 701 - Annals of Oncology. 2007
|This oncology article is a stub. You can help Wikipedia by expanding it.|